Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Biodesix Announces Publication of a New Nodify CDT® Clinical Validation Study
-
Blue Star Families Celebrates Landmark Quality-of-Life Gains for Military Families in 2025 NDAA
-
Verona Pharma Reports Strong Ohtuvayre™ Launch and Provides Preliminary Fourth Quarter and Full Year 2024 Financial Highlights
-
Agile Manufacturing, Inc. of Beaverton, Ontario, Canada adds a ninth large format 3D Systems Stereolithography (SLA) 3D printer running Accura® Xtreme White 200 material
-
Form 8.5 (EPT/RI) - Poolbeg Pharma Plc
-
Form 8.5 (EPT/RI) - Warpaint London Plc
-
From Novice to Pro: How Cross Trade Pro Levels Up Canadian Traders
-
Unique and Spectacular, Making a Strong Impression - The Main Logo of the 2025 BRTV Snake Year Spring Festival Gala Unveiled with Impact
-
Form 8.3 - Direct Line Insurance Group plc
-
Berkeley Executive Education Launches the Chief Operating Officer Program in Collaboration with Emeritus
-
Hermes in the News: A Luxurious Leap into the World of Cosplay?
-
Man Group PLC : Form 8.3 - Britvic plc
-
Women's Choice Award® Again Honors Eggland's Best as America's Most Recommended™ Egg
-
CORRECTION: 2025's Top-Rated EHR Vendors Across 40 Medical & Surgical Specialties: Black Book Insights Into Innovation and Client-Centric Excellence
-
Net Asset Value(s)
-
Diana Shipping Inc. Announces Final Results of Self Tender Offer for Shares of Common Stock
-
Arkema: Disclosure of Trading in Own Shares From 30 December to 03 January 2025
-
Buyback of Class B shares in Essity during week 1, 2025
-
Baden Capital Acquires OrCal, Inc., Expanding Its Presence in Agricultural Solutions
-
JPMorganChase Survey: Businesses Ring in the New Year with Renewed Optimism
-
Genesis Updates Wildfire and Mining Modules Strategy and Software
-
Prytime Medical Announces First in European Use of New Extended Safe Occlusion Time Catheter
-
U.S. FDA Granted Priority Review to Dizal's Sunvozertinib New Drug Application
-
VeroFORECAST Predicts Moderate Home Price Growth In 2025
-
Ambarella Expands N1 Edge GenAI Family With SoC Targeted at On-Premise Multi-Channel VLM and NN Processing in Under 20 Watts
-
Endologix Announces Leadership Transition
-
dynaCERT Features its HydraGEN™ Technology at the Dakar 2025 Truck Race
-
AI-Supported Mammography Revolutionizes Breast Cancer Detection: Landmark German Study Proves Real-World Impact
-
TRREB: Housing Market Gets More Affordable in 2024 with Lower Rates and Prices
-
Global Edtech Breakthrough: Mathleaks Introduces MathVizy, the First Math-Dedicated AI
-
Dimensional Fund Advisors Ltd. : Form 8.3 - RENEWI PLC - Ordinary Shares
-
Dimensional Fund Advisors Ltd. : Form 8.3 - INTERNATIONAL PAPER CO - Ordinary Shares
-
Dimensional Fund Advisors Ltd. : Form 8.3 - HARGREAVES LANSDOWN PLC - Ordinary Shares
-
Dimensional Fund Advisors Ltd. : Form 8.3 - BRITVIC PLC - Ordinary Shares
-
Tech Mahindra Tops India and Achieves Second Place Globally in the S&P Dow Jones Sustainability Indices 2024 for TSV IT Services Segment
-
Indian Hospitality Excellence Awards 2024: Honoring Outstanding Leadership and Talent in the Industry
-
Siemens launches new program to empower startups with cutting-edge technology
-
3 Easy Ways to Save on Payroll Software in 2025
-
Pentixapharm Receives EUR 6.77 Million for Intangible Assets Formerly Developed by Glycotope
-
Bybit Launches Fixed Rate Loan Service: A Brand-New Offering for Stability, Flexibility, and Predictable Returns
-
St. Pölten UAS: Digital Product Data for More Sustainability
-
Fixing of interest rate and refinancing triggers
-
RESULT OF RIKSBANK CERTIFICATE SALE
-
IRIS Appoints Chief Revenue Officer Jack Sebbag to Propel Global Expansion
-
IRIS Software Group Deepens its Commitment to Customer Service
-
CIFF Guangzhou 2025 Preview: A Focus on Creative Design and Trade Upgrades
-
HL Mando and HL Klemove Jointly Participate in CES 2025
-
Shanghai Korain Biotech Leverages Bioz Badges to Boost Sales and Highlight Product Credibility
-
Exploring the Power of Journeys: TESSAN and Rachael Yamagata Premiere Exclusive Documentary
-
Study Shows 90% of Persistent Lyme Patients Excluded from Clinical Trials
